1
|
Jiang H, Li DZ. Early Onset of Severe Anemia Caused by Hb Calgary ( HBB: C.194G > T): Another Case Report. Hemoglobin 2024; 48:118-120. [PMID: 38344813 DOI: 10.1080/03630269.2024.2315188] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/15/2023] [Accepted: 01/30/2024] [Indexed: 05/29/2024]
Abstract
Unstable hemoglobin (Hb) variants are a rare cause of congenital hemolytic anemia. We describe a Chinese girl who presented with transfusion-dependent anemia in early infancy. Her diagnosis of Hb Calgary [β64(E8)Gly > Val; HBB:c.194G > T] was not made until molecular testing was performed at the age of 5 years. Our case highlights the importance of early genetic testing in order to make the diagnosis, which may not only be useful for patient management and family counseling, but also for avoiding further unnecessary investigative attempts.
Collapse
Affiliation(s)
- Hua Jiang
- Department of Hematology/Oncology, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong Province, People's Republic of China
| | - Dong-Zhi Li
- Prenatal Diagnostic Center, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong province, People's Republic of China
| |
Collapse
|
2
|
Liang L, Ning S, Lu X, Li Y, Tian M, Qin T, Li Y. A novel mutation Hb jiangnan[β3(NA3) Leu→Lys, HBB:c.10-_11delinsAA] causing elevated Hb A 2 level. HEMATOLOGY (AMSTERDAM, NETHERLANDS) 2022; 27:772-777. [PMID: 35793787 DOI: 10.1080/16078454.2022.2095692] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
OBJECTIVES To report the hematolgocial and molecular features of a nove β-globin variant in a Chinese fimaly. METHODS The proband was a 19-year-old Chinese man whose Hb analysis by HPLC for thalassemia revealed an abnormal peak. Hb analysis was performed by HPLC and CE. Gap-PCR and PCR-reverse dot blot hybridization (PCR-RDB) were used to detect the common mutations in Chinese population. DNA sequencing was used to determine the Hb variant. RESULTS The Hb variant and Hb A can be separated but co-elutes with Hb F by the CE method. However, the variant can be separated from Hb A0, Hb F, and Hb A2 using HPLC. DNA sequencing showed a mutation of codon 3 in the β-globin gene. His wife's HPLC revealed a high value of Hb A2, which proved to be the Hb E using PCR-RDB. CONCLUSION It was the first report of the mutation, so we named it Hb Jiangnan according to the place of residence of the proband. It can be separated by HPLC but not CE. Hb Jiangnan can cause an increased level of Hb A2.
Collapse
Affiliation(s)
- Liang Liang
- Center for Medical Genetics and Prenatal Diagnosis, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China
| | - Shuting Ning
- Department of Obstetrics, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China
| | - Xiaocai Lu
- Department of medical laboratory, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China
| | - Yingwei Li
- Department of Obstetrics, Jiangbin Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China
| | - Mao Tian
- Center for Medical Genetics and Prenatal Diagnosis, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China
| | - Ting Qin
- Center for Medical Genetics and Prenatal Diagnosis, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China
| | - Youqiong Li
- Center for Medical Genetics and Prenatal Diagnosis, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, People's Republic of China
| |
Collapse
|
3
|
Ju AP, Zheng LH, Fu XT, Liu SX, Li YQ. Hb Huadu [α124(H7)Ser→Thr ( TCC> ACC), HBA2: c.373T>A]: A Novel Variant of the α-Globin Gene. Hemoglobin 2022; 46:335-337. [PMID: 36524388 DOI: 10.1080/03630269.2022.2151464] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/23/2022]
Abstract
Here, we report a novel α chain hemoglobin (Hb) variant found during routine thalassemia screening. This Hb variant can be detected by capillary electrophoresis (CE) but cannot be recognized by high performance liquid chromatography (HPLC). Sanger sequencing revealed a heterozygous missense substitution at nucleotide 373 on the HBA2 gene, which results in the replacement of serine by threonine at codon 124 [α124(H7)Ser→Thr (TCC>ACC), HBA2: c.373T>A]. It is the first report of this variant, named Hb Huadu for the birthplace of the proband. In addition, the proband coinherited the heterozygous codons 41/42 (-TTCT) (HBB: c126_129delCTTT) on the β-globin gene.
Collapse
Affiliation(s)
- Ai-Ping Ju
- Department of Medical Laboratory, Huadu Maternal and Neonatal Healthcare Hospital of Guangzhou, Huzhong Hospital, Guangzhou, Guangdong Province, People's Republic of China
| | - Li-Hong Zheng
- Center for Medical Genetics and Prenatal Diagnosis, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China
| | - Xiao-Tong Fu
- Department of Clinical Medicine, Nanchang University Queen Mary School, Nanchang, Jiangxi Province, People's Republic of China
| | - Shu-Xian Liu
- Department of Medical Laboratory, Huadu Maternal and Neonatal Healthcare Hospital of Guangzhou, Huzhong Hospital, Guangzhou, Guangdong Province, People's Republic of China
| | - You-Qiong Li
- Center for Medical Genetics and Prenatal Diagnosis, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Autonomous Region, People's Republic of China
| |
Collapse
|
4
|
Huang YY, Huang J, Ye LH, Liang L, Li YQ. Hb Laibin [β96(FG3)Leu→Arg; HBB: c.290T>G]: A Novel Hemoglobin Variant Described in a Chinese Family. Hemoglobin 2022; 46:187-190. [PMID: 35616292 DOI: 10.1080/03630269.2022.2069576] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
We report a novel β chain hemoglobin (Hb) variant found in a Chinese family. A high level of Hb F was observed on capillary electrophoresis (CE). However, high performance liquid chromatography (HPLC) showed a high level of Hb A2. DNA sequencing revealed a single base substitution (T>G) at codon 96 of exon 2 of the β-globin gene. This alters the normally encoded leucine to arginine [β96(FG3)Leu→Arg; HBB: c.290T>G] that we propose to name Hb Laibin for the region of origin of the proband. The pedigree study showed that it was inherited from his mother.
Collapse
Affiliation(s)
- Yuan-Yuan Huang
- Department of Clinical Laboratory, Women and Children Care Hospital of Laibin, Laibin, Guangxi Zhuang Autonomous Region, Laibin, People's Republic of China
| | - Jun Huang
- Department of Clinical Laboratory, Women and Children Care Hospital of Laibin, Laibin, Guangxi Zhuang Autonomous Region, Laibin, People's Republic of China
| | - Li-Hua Ye
- Department of Clinical Laboratory, Women and Children Care Hospital of Laibin, Laibin, Guangxi Zhuang Autonomous Region, Laibin, People's Republic of China
| | - Liang Liang
- Center for Medical Genetics and Prenatal Diagnosis, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, People's Republic of China
| | - You-Qiong Li
- Center for Medical Genetics and Prenatal Diagnosis, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, People's Republic of China
| |
Collapse
|
5
|
Su HX, Li F, Liang L, Zou XB, Li YQ. Detection of Hb Yulin [β13(A10)Ala→Val, HBB: c.41C>T] by Matrix-Assisted Laser Desorption Ionization-Time-of-Flight Mass Spectrometry. Hemoglobin 2022; 46:176-179. [PMID: 35535583 DOI: 10.1080/03630269.2022.2043356] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022]
Abstract
We report a rare hemoglobin (Hb) variant on the β-globin gene, which was detected in a female from Yulin City, Guangxi Autonomous Region, People's Republic of China (PRC), during routine thalassemia screening. The Hb variant remained unnoticed using capillary electrophoresis (CE) and high performance liquid chromatography (HPLC), while an additional peak was observed by matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF) mass spectrometry (MS). DNA sequencing revealed the GCC>GTC substitution at codon 13 on the β-globin gene, causing a substitution of alanine to valine. The mutation is only described in the ITHANET database but no Hb variant name and other information, so we named it Hb Yulin after the place of origin of the proband in this study. Hb Yulin is clinically silent and easily leads to misdiagnosis during hemoglobinopathies screening based on the common methods of HPLC and CE.
Collapse
Affiliation(s)
- Heng-Xue Su
- Department of Clinical Laboratory, Hospital of Rong County, Yulin, Guangxi Autonomous Region, People's Republic of China
| | - Feng Li
- Department of Clinical Laboratory, Hospital of Rong County, Yulin, Guangxi Autonomous Region, People's Republic of China
| | - Liang Liang
- Center for Medical Genetics and Prenatal Diagnosis, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Autonomous Region, People's Republic of China
| | - Xiang-Bin Zou
- Department of Clinical Laboratory, the Tenth People's Hospital of Nanning, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Autonomous Region, People's Republic of China
| | - You-Qiong Li
- Center for Medical Genetics and Prenatal Diagnosis, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Autonomous Region, People's Republic of China
| |
Collapse
|
6
|
Luo S, Chen X, Zeng D, Tang N, Yuan D, Zhong Q, Mao A, Xu R, Yan T. The value of single-molecule real-time technology in the diagnosis of rare thalassemia variants and analysis of phenotype-genotype correlation. J Hum Genet 2022; 67:183-195. [PMID: 34690349 PMCID: PMC8948088 DOI: 10.1038/s10038-021-00983-1] [Citation(s) in RCA: 22] [Impact Index Per Article: 11.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/29/2021] [Revised: 09/19/2021] [Accepted: 09/29/2021] [Indexed: 12/03/2022]
Abstract
To compare single-molecule real-time technology (SMRT) and conventional genetic diagnostic technology of rare types of thalassemia mutations, and to analyze the molecular characteristics and phenotypes of rare thalassemia gene variants, we used 434 cases with positive hematology screening as the cohort, then used SMRT technology and conventional gene diagnosis technology [(Gap-PCR, multiple ligation probe amplification technology (MLPA), PCR-reverse dot blot (RDB)] for thalassemia gene screening. Among the 434 enrolled cases, conventional technology identified 318 patients with variants (73.27%) and 116 patients without variants (26.73%), SMRT identified 361 patients with variants (83.18%), and 73 patients without variants (16.82%). The positive detection rate of SMRT was 9.91% higher than conventional technology. Combination of the two methods identified 485 positive alleles among 49 types of variant. The genotypes of 354 cases were concordant between the two methods, while 80 cases were discordant. Among the 80 cases, 76 cases had variants only identified in SMRT method, 3 cases had variants only identified in conventional method, and 1 false positive result by the traditional PCR detection technology. Except the three variants in HS40 and HBG1-HBG2 loci, which was beyond the design of SMRT method in this study, all the other discordant variants identified by SMRT were validated by further Sanger sequencing or MLPA. The hematological phenotypic parameters of 80 discordant cases were also analyzed. SMRT technology increased the positive detection rate of thalassemia genes, and detected rare thalassemia cases with variable phenotypes, which had great significance for clinical thalassemia gene screening.
Collapse
Affiliation(s)
- Shiqiang Luo
- grid.477238.dDepartment of Medical Genetics, Liuzhou Key Laboratory of Birth Defects Prevention and Control, Liuzhou Maternity and Child Healthcare Hospital, 545001 Liuzhou, Guangxi China ,Liuzhou Key Laboratory of Reproductive Medicine, 545001 Liuzhou, Guangxi China
| | - Xingyuan Chen
- grid.410652.40000 0004 6003 7358Department of Laboratory Medicine, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi Zhuang Autonomous Region China ,Guangxi Academy of Medical Sciences, Nanning, Guangxi Zhuang Autonomous Region China
| | - Dingyuan Zeng
- Guangxi Health Commission Key Laboratory of Birth Cohort Study in Pregnant Women of Advanced Age, 545001 Liuzhou, Guangxi China
| | - Ning Tang
- Guangxi Health Commission Key Laboratory of Birth Cohort Study in Pregnant Women of Advanced Age, 545001 Liuzhou, Guangxi China
| | - Dejian Yuan
- grid.477238.dDepartment of Medical Genetics, Liuzhou Key Laboratory of Birth Defects Prevention and Control, Liuzhou Maternity and Child Healthcare Hospital, 545001 Liuzhou, Guangxi China ,Liuzhou Key Laboratory of Reproductive Medicine, 545001 Liuzhou, Guangxi China
| | - Qingyan Zhong
- grid.477238.dDepartment of Medical Genetics, Liuzhou Key Laboratory of Birth Defects Prevention and Control, Liuzhou Maternity and Child Healthcare Hospital, 545001 Liuzhou, Guangxi China ,Liuzhou Key Laboratory of Reproductive Medicine, 545001 Liuzhou, Guangxi China
| | - Aiping Mao
- Berry Genomics Corporation, 102200 Beijing, China
| | - Ruofan Xu
- Berry Genomics Corporation, 102200 Beijing, China
| | - Tizhen Yan
- Department of Medical Genetics, Liuzhou Key Laboratory of Birth Defects Prevention and Control, Liuzhou Maternity and Child Healthcare Hospital, 545001, Liuzhou, Guangxi, China. .,Liuzhou Key Laboratory of Reproductive Medicine, 545001, Liuzhou, Guangxi, China.
| |
Collapse
|
7
|
Qin YY, Huang XJ, Ma YL, Qin JX, Liang L, Li YQ. Hb Dahua [β59(E3)Lys→Met; HBB: c.179A>T] a Novel Variant on the β-Globin Gene. Hemoglobin 2021; 45:332-334. [PMID: 34957905 DOI: 10.1080/03630269.2021.2016442] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
Abstract
We report a novel hemoglobin (Hb) variant found in a Chinese individual from the Guangxi Zhuang Autonomous Region of the People's Republic of China. The proband was a 6-month-old boy who came from Dahua county, Hechi City. Capillary zone electrophoresis (CZE) showed an abnormal peak (51.2%) in zone 13. However, capillary isoelectric focusing electrophoresis (CIFE) presented an unknown peak in zone Bart's (51.4%). High performance liquid chromatography (HPLC) displayed an unknown peak (42.1%) at retention time 2.44 min., eluting before Hb A0. Direct DNA sequencing of the β-globin gene revealed heterozygosity for a missense mutation at codon 59 (AAG>ATG), causing a lysine to methionine substitution [β59(E3)Lys→Met; HBB: c.179A>T]. We decided to name the variant Hb Dahua for the place of origin of the proband.
Collapse
Affiliation(s)
- Yan-Ye Qin
- Department of Clinical Laboratory, Women and Children Care Hospital of Dahua County, Hechi, Guangxi, China
| | - Xiao-Juan Huang
- Department of Clinical Laboratory, Women and Children Care Hospital of Dahua County, Hechi, Guangxi, China
| | - Yue-Liao Ma
- Department of Clinical Laboratory, Women and Children Care Hospital of Dahua County, Hechi, Guangxi, China
| | - Jiao-Xiu Qin
- Department of Clinical Laboratory, Women and Children Care Hospital of Dahua County, Hechi, Guangxi, China
| | - Liang Liang
- Center for Medical Genetics and Prenatal Diagnosis, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China
| | - You-Qiong Li
- Center for Medical Genetics and Prenatal Diagnosis, People's Hospital of Guangxi Zhuang Autonomous Region, Nanning, Guangxi, China
| |
Collapse
|
8
|
Martin G, Grimholt RM, Le D, Bechensteen AG, Klingenberg O, Fjeld B, Fourie T, Perrier R, Proven M, Henderson SJ, Roy NBA. Hb Calgary ( HBB: c.194G>T): A Highly Unstable Hemoglobin Variant with a β-Thalassemia Major Phenotype. Hemoglobin 2021; 45:215-219. [PMID: 34311670 DOI: 10.1080/03630269.2021.1956947] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
Abstract
We describe two unrelated patients, both heterozygous for an unstable hemoglobin (Hb) variant named Hb Calgary (HBB: c.194G>T) that causes severe hemolytic anemia and dyserythorpoietic, resulting in transfusion dependence and iron overload. The molecular pathogenesis is a missense variation on the β-globin gene, presumed to lead to an unstable Hb. The phenotype of Hb Calgary is particularly severe presenting as transfusion-dependent anemia in early infancy, precluding phenotypic diagnosis and highlighting the importance of early genetic testing in order to make an accurate diagnosis.
Collapse
Affiliation(s)
- Georgina Martin
- Department of Pediatric Hematology, University of Calgary, Calgary, Canada
| | - Runa M Grimholt
- Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.,Department of Life Sciences and Health, Oslo Metropolitan University, Oslo, Norway
| | - Doan Le
- Department of Pediatric Hematology, University of Calgary, Calgary, Canada
| | - Anne G Bechensteen
- Department of Paediatric Haematology and Oncology, Oslo University Hospital, Oslo, Norway
| | - Olav Klingenberg
- Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.,Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Bente Fjeld
- Department of Medical Biochemistry, Oslo University Hospital, Oslo, Norway.,Institute of Clinical Medicine, University of Oslo, Oslo, Norway
| | - Thomas Fourie
- Department of Pathology and Laboratory Medicine, University of Calgary, Calgary, Canada
| | - Renee Perrier
- Department of Medical Genetics and Pediatrics, University of Calgary, Calgary, Canada
| | - Melanie Proven
- Oxford Molecular Diagnostics Centre, Oxford University Hospitals, National Health Service (NHS) Foundation Trust, Oxford, UK.,National Institute of Health Research (NIHR), Bristol Biomedical Research Centre (BRC), Oxford, UK
| | - Shirley J Henderson
- Oxford Molecular Diagnostics Centre, Oxford University Hospitals, National Health Service (NHS) Foundation Trust, Oxford, UK.,National Institute of Health Research (NIHR), Bristol Biomedical Research Centre (BRC), Oxford, UK
| | - Noémi B A Roy
- National Institute of Health Research (NIHR), Bristol Biomedical Research Centre (BRC), Oxford, UK.,Department of Haematology, Oxford University Hospitals, NHS Foundation Trust, Oxford, UK
| |
Collapse
|